Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Nickhill Bhakta, Kalatu Davies, PhD, Jesse Turner, PhD, Yichen Chen, PhD, Jaime Flerlage, MD MS, I-Chan Huang, PhD, Melissa M. Hudson, MD, John T. Lucas, Jr., MD MS, Monika Metzger, MD, Leslie L. Robison, PhD, F. Lennie Wong, PhD

Blood (2019) 134 (Supplement_1): 267.

https://doi.org/10.1182/blood-2019-124907

Published: 2019

Journal Articles

Association Between Chronic Pulmonary Conditions and Neurocognitive Function in Long-Term Survivors of Childhood Hodgkin Lymphoma

Yin Ting Cheung, PhD, Noah D. Sabin, MD JD, Daniel A. Mulrooney, MD, Kirsten K. Ness, PhD, Matthew J Krasin, MD, Tara M. Brinkman, PhD, Pia Banerjee, PhD, Deokumar Srivastava, PhD, Leslie L. Robison, PhD, Melissa M. Hudson, MD, Kevin R. Krull, PhD

Blood (2016) 128 (22): 2404.

https://doi.org/10.1182/blood.V128.22.2404.2404

Published: 2016

Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS

Blood (2016) 128 (22): 924.

https://doi.org/10.1182/blood.V128.22.924.924

Published: 2016

Journal Articles

Risk Adapted Treatment in Childhood Hodgkin's Lymphoma: Outcome and Changing Epidemiologic Features in 25 Years

Rejin Kebudi, MD Prof, Sema Bay Buyukkapu, MD, Omer Gorgun, MD, Fulya Yaman Agaoglu, MD, Bulent Zulfikar, MD, Inci Ayan, MD, Ayca Iribas, MD, Dizdar Yavuz, MD, Oner Dogan, MD, Emin Darendeliler, MD

Blood (2016) 128 (22): 4158.

https://doi.org/10.1182/blood.V128.22.4158.4158

Published: 2016

Journal Articles

Pediatric Hodgkin’s Lymphoma: 5-Year Experience at Single Center in Pakistan

Shazia Riaz, MD, Safia Khan, MBBS, FCPS pediatrics, Farhana Badar

Blood (2014) 124 (21): 5455.

https://doi.org/10.1182/blood.V124.21.5455.5455

Published: 2014

Journal Articles

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Smita Bhatia, MD, MPH, Cor van den Bos, MD, PhD, Can-Lan Sun, PhD, Jillian Birch, MD, Lisa Diller, MD, Kimberley Dilley, MD, MPH, FAAP, Jill Ginsberg, Laura Therese Martin, MD, Rajaram Nagarajan, MD, MS, Joseph P. Neglia, MD, MPH, Monica Terenziani, MD, David Tishler, MD, Anna T Meadows, MD, Leslie L. Robison, PhD, MPH, Odile Oberlin, MD, Jennifer P. Berano Teh, MD

Blood (2013) 122 (21): 2992.

https://doi.org/10.1182/blood.V122.21.2992.2992

Published: 2013

Journal Articles

Central Nervous System Integrity in Adult Survivors of Childhood Hodgkin Lymphoma,

Kevin R. Krull, PhD, Noah D. Sabin, MD, JD, Wilburn E. Reddick, PhD, Liang Zhu, PhD, Gregory T. Armstrong, MD, Daniel M. Green, MD, Deo Kumar Srivastava, PhD, Monika L. Metzger, MD, MS, Leslie L. Robison, PhD, Melissa M. Hudson, MD

Blood (2011) 118 (21): 3647.

https://doi.org/10.1182/blood.V118.21.3647.3647

Published: 2011

Journal Articles

Variants At 6q21 Associated with Radiation-Induced Second Malignancies After Hodgkin Lymphoma Differentially Regulate PRDM1 Expression Following Radiation Exposure

Kenan Onel, MD, PhD, Timothy Best, Shan Yu

Blood (2011) 118 (21): 431.

https://doi.org/10.1182/blood.V118.21.431.431

Published: 2011

Journal Articles

Coordinate Regulation of NF-κB Subunit Expression in EBV Negative, but Not EBV Positive, Pediatric Hodgkin’s Lymphoma

Terzah M. Horton, MD, PhD, Andrea N Sheehan, MD, Dolores Lopez-Terrada, MD, Robert Edward Hutchison, MD, Sonia Narendra, MD, Meghan A. Higman, MD, PhD, Meng-Fen Wu, PhD, Hao Liu, PhD

Blood (2008) 112 (11): 521.

https://doi.org/10.1182/blood.V112.11.521.521

Published: 2008

Journal Articles

Pericardial Involvement in Newly Diagnosed Children and Adolescents with Pediatric Hodgkin’s Disease at a Single Children’s Cancer Hospital.

Hamid Bashir, MD, Monika Metzger, MD, Matt Krasin, MD, Sue Kaste, MD, Scott Howard, MD, Melissa M. Hudson, MD.

Blood (2005) 106 (11): 4645.

https://doi.org/10.1182/blood.V106.11.4645.4645

Published: 2005

Journal Articles

The Impact of Central Quality Assurance Review Prior to Radiation Therapy on Protocol Compliance: POG 9426, a Trial in Pediatric Hodgkin’s Disease.

Nancy P. Mendenhall, MD, Josh Meyer, MD, Jonathan Williams, MD, Cameron Tebbi, MD, Sandy Kessel, Fran Laurie, T.J. Fitzgerald, MD

Blood (2005) 106 (11): 753.

https://doi.org/10.1182/blood.V106.11.753.753

Published: 2005

Journal Articles

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

Markus Tiemann, MD, Alexander Claviez, MD, Heike Lueders, Martin Zimmermann, Guenther Schellong, MD, Wolfgang Doerffel, MD, Reza Parwaresch, MD

Blood (2004) 104 (11): 3118.

https://doi.org/10.1182/blood.V104.11.3118.3118

Published: 2004

NARROW

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Association Between Chronic Pulmonary Conditions and Neurocognitive Function in Long-Term Survivors of Childhood Hodgkin Lymphoma

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Risk Adapted Treatment in Childhood Hodgkin's Lymphoma: Outcome and Changing Epidemiologic Features in 25 Years

Pediatric Hodgkin’s Lymphoma: 5-Year Experience at Single Center in Pakistan

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Central Nervous System Integrity in Adult Survivors of Childhood Hodgkin Lymphoma,

Variants At 6q21 Associated with Radiation-Induced Second Malignancies After Hodgkin Lymphoma Differentially Regulate PRDM1 Expression Following Radiation Exposure

Coordinate Regulation of NF-κB Subunit Expression in EBV Negative, but Not EBV Positive, Pediatric Hodgkin’s Lymphoma

Pericardial Involvement in Newly Diagnosed Children and Adolescents with Pediatric Hodgkin’s Disease at a Single Children’s Cancer Hospital.

The Impact of Central Quality Assurance Review Prior to Radiation Therapy on Protocol Compliance: POG 9426, a Trial in Pediatric Hodgkin’s Disease.

Proliferation Characteristics in Pediatric Hodgkin’s Disease Point to a Cell Cycle Arrest in G 1 Phase.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only